Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FZG31
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,357
Award facts
- Contract value 100% obligated
- $11,357.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,357.40 to DMS Pharmaceutical Group Inc. for the supply of Nucala 100 mg/ml auto-injector units. The award, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the contract at its primary location. The delivery order represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Logistics Agency procurement. The company's core business involves distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. The SPE2DB IDC enables the DLA to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs across Department of Defense healthcare sites globally. This particular delivery order for Nucala auto-injector units supports the agency's ongoing medical supply requirements for military health facilities.
Quick answers
Who was awarded contract SPE2DB25FZG31?
SPE2DB25FZG31 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FZG31 worth?
The government has obligated $11,357 on SPE2DB25FZG31.
Is contract SPE2DB25FZG31 an order under another contract?
Yes. SPE2DB25FZG31 is a delivery order under SPE2DB22D9205, an indefinite delivery contract.
Was contract SPE2DB25FZG31 competed?
The extent of competition for SPE2DB25FZG31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award